City

Bethesda (1)

Ho Chi Minh (1)

Iowa City (1)

Pozzilli (1)

Rochester (1)

Scottsdale (1)

Condition

Chorea (1)

Drug Resistant Epilepsy (1)

Epilepsy (1)

Executive Dysfunction (1)

Huntington Disease (1)

Parkinson's Disease (1)

Tetanus (1)

Overall Status

Completed (2)

Recruiting (1)

Terminated (1)

Withdrawn (1)

Phase

phase 1 (2)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS) (2)

Neuromed IRCCS (1)

Oxford University Clinical Research Unit, Vietnam (1)

University of Iowa (1)

Collaborator

Cure Huntington's Disease Initiative (CHDI) (1)

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam (1)

Mayo Clinic (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

University of Rochester (1)

Intervention

muscimol (2)

20mg daily citalopram (1)

ex-vivo study (1)

human tetanus immunoglobulin (1)

intramuscular antitoxin (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

other (1)

procedure (1)

Funder Type

Other (3)

NIH (2)

Study Type

Interventional (4)

Observational (1)

Muscimol

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Inhibitory Neurotransmission in the Human Epileptic Brain.

Recruiting

Drug Resistant Epilepsy

ex-vivo study

Pozzilli, Isernia, Italy

IRCCS INM Neuromed

Jul 29, 2022

Epilepsy Trial run by the NINDS (Muscimol)

Terminated

Epilepsy

Muscimol

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jul 3, 2018

Parkinson's Disease Trial (Muscimol)

Withdrawn

Parkinson's Disease

Muscimol

(no location specified)

Oct 5, 2017

Tetanus Trial in Ho Chi Minh (Human tetanus immunoglobulin, Intramuscular antitoxin)

Completed

Tetanus

Human tetanus immunoglobulin
Intramuscular antitoxin

Ho Chi Minh, Vietnam

Hospital for Tropical Diseases

May 28, 2020

Huntington Disease, Chorea, Executive Dysfunction Trial in Scottsdale, Iowa City, Rochester (20mg daily citalopram, Placebo)

Completed

Has Results

Huntington Disease
+2 more

20mg daily citalopram
Placebo

Scottsdale, Arizona
+2 more

Feb 8, 2013